期刊文献+

Management of hilar cholangiocarcinoma in the North of England: Pathology, treatment, and outcome 被引量:37

Management of hilar cholangiocarcinoma in the North of England: Pathology, treatment, and outcome
下载PDF
导出
摘要 AIM: To assess the management and outcome of hilar cholangiocarcinoma (Klatskin tumor) in a single tertiary referral center.METHODS: The notes of all patients with a diagnosis of hilar cholangiocarcinoma referred to our unit for over an 8-year period were identified and retrospectively reviewed. Presentation, management and outcome were assessed.RESULTS: Seventy-five patients were identified. The median age was 64 years (range 34-84 years). Male to female ratio was 1:1. Eighty-nine percent of patients presented with jaundice. Most patients referred were under Bismuth classification 3a, 3b or 4. Seventy patients required biliary drainage, 65 patients required 152percutaneous drainage procedures, and 25 had other complications. Forty-one patients had 51 endoscopic drainage procedures performed (15 failed). Of these,36 subsequently required percutaneous drainage. The median number of drainage procedures for all patients was three, 18 patients underwent resection (24%), nine had major complications and three died post-operatively.The 5-year survival rate was 4.2% for all patients, 21%for resected patients and 0% for those who did not undergo resection (P = 0.0021). The median number of admissions after diagnosis in resected patients was two and three in non-resected patients (P<0.05).Twelve patients had external-beam radiotherapy, seven brachytherapy, and eight chemotherapy. There was no significant benefit in terms of survival (P = 0.46) or hospital admissions.CONCLUSION: Resection increases survival but carries the risk of significant morbidity and mortality.Percutaneous biliary drainage is almost always necessary and endoscopic drainage should be avoided if possible. AIM: To assess the management and outcome of hilar cholangiocarcinoma (Klatskin tumor) in a single tertiary referral center.METHODS: The notes of all patients with a diagnosis of hilar cholangiocarcinoma referred to our unit for over an 8-year period were identified and retrospectively reviewed. Presentation, management and outcome were assessed.RESULTS: Seventy-five patients were identified. The median age was 64 years (range 34-84 years). Male to female ratio was 1:1. Eighty-nine percent of patients presented with jaundice. Most patients referred were under Bismuth classification 3a, 3b or 4. Seventy patients required biliary drainage, 65 patients required 152 percutaneous drainage procedures, and 25 had other complications. Forty-one patients had 51 endoscopic drainage procedures performed (15 failed). Of these, 36 subsequently required percutaneous drainage. The median number of drainage procedures for all patients was three, 18 patients underwent resection (24%), nine had major complications and three died post-operatively. The 5-year survival rate was 4.2% for all patients, 21% for resected patients and 0% for those who did not undergo resection (P = 0.0021). The median number of admissions after diagnosis in resected patients was two and three in non-resected patients (P〈0.05). Twelve patients had external-beam radiotherapy, seven brachytherapy, and eight chemotherapy. There was no significant benefit in terms of survival (P = 0.46) or hospital admissions.CONCLUSION: Resection increases survival but carries the risk of significant morbidity and mortality. Percutaneous biliary drainage is almost always necessary and endoscopic drainage should be avoided if possible.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第48期7625-7630,共6页 世界胃肠病学杂志(英文版)
关键词 Hilar cholangiocarcinoma PATHOLOGY TREATMENT OUTCOME ENGLAND 胆管癌 病理学 治疗 临床表现
  • 相关文献

参考文献34

  • 1[1]Taylor-Robison SD,Toledano MB,Arora S,Keegan TJ,Hargreaves S,Beck A,Khan SA,Elliott P,Thomas HC.Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.Gut 2001; 48:816-820 被引量:1
  • 2[2]Nakeeb A,Pitt HA,Sohn TA,Coleman J,Abrams RA,Piantadosi S,Hruban RH,Lillemoe KD,Yeo CJ,Cameron JL.Cholangiocarcinoma A spectrum of intrahepatic,perihilar,and distal tumours.Ann Surg 1996.224:463-447 被引量:1
  • 3[3]Burke EC,Jarnagin WR,Hochwald SN,Pisters PW,Fong Y,Blumgart LH.Hilar Cholangiocarcinoma:patterns of spread,the importance of hepatic resection for curative operation,and a pre-surgical clinical staging system.Ann Surg 1998; 228:385-394 被引量:1
  • 4[4]Weinbren K,Mutum SS.Pathological aspects of cholangiocarcinoma.J Pathol 1983; 139:217-238 被引量:1
  • 5[5]Chamberlain RS,Blumgart LH.Hilar cholangiocarcinoma:a review and commentary.Ann Surg Oncol 2000; 7:55-66 被引量:1
  • 6[6]Lee SG,Lee YJ,Park KM,Hwang S,Min PC.One hundred and eleven liver resections for hilar bile duct cancer.J Hepatobiliary Pancreat Surg 2000; 7:135-141 被引量:1
  • 7[7]Gazzaniga GM,Filauro M,Bagarolo C,Mori L.Surgery for hilar cholangiocarcinoma:an Italian experience.J Hepatobiliary Pancreat Surg 2000; 7:122-127 被引量:1
  • 8[8]Pichlmayr R,Weimann A,Ringe B.Indications for liver transplantation in hepatobiliary malignancy.Hepatology 1994;20:33S-40S 被引量:1
  • 9[9]Madariaga JR,Iwatsuki S,Todo S,Lee RG,Irish W,Starzl TE.Liver resection for hilar and peripheral cholangiocarcinomas:a study of 62 cases.Ann Surg 1998; 227:70-79 被引量:1
  • 10[10]Launois B,Reding R,Lebeau G,Buard JL.Surgery for hilar cholangiocarcinoma:French experience in a collective surveyof 552 extrahepatic bile duct cancers.J Hepatobiliary Pancreat Surg 2000; 7:128-134 被引量:1

同被引文献180

引证文献37

二级引证文献293

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部